REM sleep and central monoamine oxidase inhibition.
D000293:Adolescent; D000328:Adult; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D003863:Depression / Q000188:drug therapy; D004569:Electroencephalography; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010624:Phenelzine / Q000494:pharmacology* / Q000627:therapeutic use; D010648:Phenylacetates / Q000134:cerebrospinal fluid / Q000378:metabolism*; D011339:Probenecid / Q000494:pharmacology; D012895:Sleep, REM
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D010624:Phenelzine; D011339:Probenecid